Satinder Jagdev
Publications by Year
Research Areas
Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Prostate Cancer Treatment and Research, Cancer Diagnosis and Treatment
Most-Cited Works
- → Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial(2020)514 cited
- → Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2–Positive Metastatic Bladder Cancer(2017)197 cited
- → Skeletal complications and survival in renal cancer patients with bone metastases(2010)192 cited
- → Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma(2014)111 cited
- → Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)(2020)80 cited
- → Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial(2024)70 cited
- → Long-term outcomes of image-guided ablation and laparoscopic partial nephrectomy for T1 renal cell carcinoma(2022)38 cited
- → Final results of a multicenter, open-label phase II trial of dovitinib (TKI258) in patients with advanced urothelial carcinoma with either mutated or nonmutated FGFR3.(2013)34 cited
- → Irreversible electroporation (IRE) in renal cell carcinoma (RCC): a mid-term clinical experience(2021)31 cited
- → Randomized Phase II Study Investigating Pazopanib Versus Weekly Paclitaxel in Relapsed or Progressive Urothelial Cancer(2017)30 cited